Intelligence
Ron Stotish, CEO de AquaBounty Technologies, cree que el salmón genéticamente modificado no es una amenaza para sus oponentes y que la perspectiva de AquAdvantage es buena. Con la compra de la instalación RAS de Bell Fish Co., la comercialización comenzará pronto.
Innovation & Investment
Ron Stotish, CEO of AquaBounty Technologies, believes genetically modified salmon is no threat to its opponents and the outlook for AquAdvantage is good. With its purchase of the Bell Fish Co. RAS facility, commercialization will soon commence.
Innovation & Investment
Ron Stotish, CEO of AquaBounty Technologies, discusses being the first to produce a genetically modified (GM) farmed salmon deemed safe for consumption, the controversy surrounding his company's product and the potential of biotechnology.
Intelligence
After a 20-year process, a genetically modified fish earned U.S. Food and Drug Administration approval, reigniting one of the seafood industry’s most intriguing controversies. Here are 10 key downloads from the groundbreaking decision over AquAdvantage salmon.
Intelligence
If approved by FDA, fast-growing genetically modified salmon will provide a safe and nutritious product similar to other farmed Atlantic salmon.